The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Stock and Other Ownership Interests - Individual stock and mutual funds
Honoraria - Healthtronics
Speakers' Bureau - Janssen Research & Development
Research Funding - Clovis Oncology; Ferring; Janssen Research & Development; Medivation; Veru
First results from TITAN: A phase III double-blind, randomized study of apalutamide (APA) versus placebo (PBO) in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) receiving androgen deprivation therapy (ADT).
 
Kim N. Chi
Honoraria - Astellas Pharma; Bayer; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; ESSA; Janssen; Lilly/ImClone; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst); Tokai Pharmaceuticals (Inst)
 
Neeraj Agarwal
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; EMD Serono; Exelixis; Foundation One Inc; Genentech/Roche; Lilly; Medivation/Astellas; Merck; Nektar; Novartis; Pfizer; Pharmacyclics
Research Funding - Active Biotech (Inst); Amgen (Inst); AstraZeneca (Inst); Bavarian Nordic (Inst); Bayer (Inst); BN ImmunoTherapeutics (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celldex (Inst); Eisai (Inst); Exelixis (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immunomedics (Inst); Janssen (Inst); Merck (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Takeda (Inst); TRACON Pharma (Inst)
 
Anders Bjartell
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Bayer; Ferring
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ferring (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Ferring; Janssen-Cilag
 
Byung Ha Chung
Honoraria - Astellas Pharma; Ipsen; JW Pharmaceutical; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Astellas Pharma; Handok; Ipsen; Janssen; JW Pharmaceutical; Takeda
Research Funding - AstraZeneca; Bayer; Janssen Research & Development; Myovant Sciences; Pfizer; Roche
 
Andrea Juliana Pereira de Santana Gomes
No Relationships to Disclose
 
Robert W. Given
No Relationships to Disclose
 
Álvaro Juárez Soto
Consulting or Advisory Role - Astellas Pharma; Bayer; Coloplast; Janssen Research & Development; Pfizer
Research Funding - Bayer; Janssen Research & Development
 
Axel Stuart Merseburger
Honoraria - Astellas Pharma; Janssen-Cilag
Consulting or Advisory Role - Astellas Pharma; Janssen-Cilag
Speakers' Bureau - Astellas Pharma; Janssen-Cilag
Travel, Accommodations, Expenses - Astellas Pharma; Janssen-Cilag
 
Mustafa Ozguroglu
No Relationships to Disclose
 
Hirotsugu Uemura
Consulting or Advisory Role - Bayer; Janssen Research & Development; Sanofi
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Janssen Research & Development; MSD; Sanofi; Takeda
Research Funding - Astellas Pharma; AstraZeneca; Janssen Research & Development; Sanofi; Taiho Pharmaceutical; Takeda
Other Relationship - Astellas Pharma; Bayer; Janssen Research & Development; MSD; Novartis
 
Dingwei Ye
No Relationships to Disclose
 
Kris Deprince
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Vahid Naini
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Jinhui Li
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Shinta Cheng
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Margaret K. Yu
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
Research Funding - Janssen Oncology
Travel, Accommodations, Expenses - Janssen Oncology
 
Ke Zhang
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Julie S. Larsen
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Sharon Anne McCarthy
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Simon Chowdhury
Honoraria - Clovis Oncology; Novartis
Consulting or Advisory Role - Astellas Pharma; Bayer; Clovis Oncology; Janssen-Cilag; Pfizer
Speakers' Bureau - Pfizer
Research Funding - Sanofi/Aventis (Inst)